Cholecystokinin receptor antagonists.
Since 1979 three classes of cholecystokinin receptor antagonists have been described: 1) derivatives of cyclic nucleotides, 2) derivatives of amino acids, and 3) C-terminal fragments or partial sequences of cholecystokinin. These various antagonists share a number of common features, such as their specific, reversible, and competitive actions, but they vary in the potency with which they inhibit the actions of cholecystokinin.
D000596:Amino Acids / Q000494:pharmacology*; D000681:Amylases / Q000378:metabolism; D000818:Animals; D002766:Cholecystokinin / Q000378:metabolism*; D007700:Kinetics; D009712:Nucleotides, Cyclic / Q000494:pharmacology*; D011956:Receptors, Cell Surface / Q000187:drug effects*; D011949:Receptors, Cholecystokinin; D013329:Structure-Activity Relationship
D000596:Amino Acids; D009712:Nucleotides, Cyclic; D011956:Receptors, Cell Surface; D011949:Receptors, Cholecystokinin; D002766:Cholecystokinin; D000681:Amylases